It is unlike Baraclude generics will covet the Viread market

Launched with their low-price advantage, generic products of ‘Baraclude(generic name: entecavir),’ a chronic hepatitis B treatment, seem hard to impact on the market owned by ‘Viread(generic name: tenofovir).’

This is because the government has expressed its opinion that it is inappropriate to approve replacement prescription of Viread which prescribed a primary treatment to low-price Baraclud...